Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biomed Pharmacother ; 107: 1311-1317, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30257346

ABSTRACT

Albumin is a natural, biocompatible, biodegradable and nontoxic polymer and due to these features, nanoparticles made of albumin are a good system for drug or antigen delivery. Polymeric nanoparticles are being widely explored as new vaccines platforms due to the capacity of those nanoparticles to prime the immune system by providing sustained release of the antigen after injection. Biodegradable nanoparticles associated with proteins represent a promising method for in vivo delivery of vaccines. In our previous studies, bovine serum albumin nanoparticles (BSA-NPs) were identified as a promising system for in vivo delivery of microbial antigens. The aim of this work was to show the effect of BSA-NPs on skin after nanoparticles administration. The pro-inflammatory activity of BSA-NPs was evaluated using in vivo models. BSA-NPs are easily uptake by macrophagic RAW 264.7 and BHK-21 cells without any significant cytotoxicity. Histological examination of skin sections from BSA-NPs-treated mice revealed intense cellular infiltration, increased skin thickness, follicular hypertrophy, vascular congestion and marked collagenesis. Mice immunized with recombinant non-structural protein 1 (rNS1) from Dengue virus 1 and BSA-NPs showed a high seroconversion rate if compared to animals immunized only with rNS1. Therefore, the effect of BSA-NPs on skin after BSA-NPs administration has a biotechnological relevance to the rational design of vaccine formulations based on albumin nanocarriers. However in the next years future studies should be carried out to best characterize the effect of BSA-NPs on dendritic cells and establish the role of these nanoparticles as a new vaccine platform for infectious diseases or cancer.


Subject(s)
Drug Carriers/toxicity , Nanoparticles/toxicity , Serum Albumin, Bovine/toxicity , Skin/drug effects , Vaccines/administration & dosage , Animals , Cell Survival/drug effects , Drug Carriers/administration & dosage , Female , Injections, Subcutaneous , Mice , Nanoparticles/administration & dosage , Particle Size , RAW 264.7 Cells , Seroconversion , Serum Albumin, Bovine/administration & dosage , Skin/immunology , Skin/pathology , Surface Properties , Vaccines/immunology , Viral Nonstructural Proteins/administration & dosage , Viral Nonstructural Proteins/immunology
2.
J Med Virol ; 88(8): 1297-302, 2016 08.
Article in English | MEDLINE | ID: mdl-26792115

ABSTRACT

Dengue is the most prevalent arthropod-borne viral illness in humans. The overexpression of cytokines by Dengue virus (DENV) infected cells is associated with the most severe forms of the disease. Unmethylated CpG islands are related to a transcriptionally active structure, whereas methylated DNA recruits methyl-binding proteins that inhibit gene expression. Several studies have described the importance of epigenetic events in the regulation and expression of many cytokines. The purpose of the present study was to evaluate the methylation status of the IFN-γ and TNF-α promoters in DNA extracted from dengue infected patients using methylation-specific polymerase chain reaction. A high frequency of demethylation was observed in the TNF-α promoter of DENV infected patients when compared to non-infected controls. The patients with an unmethylated profile showed higher expression of TNF-α mRNA than patients with the methylated status. No difference was found in the methylation frequency between the two analyzed groups regarding the IFN-γ promoter or in the expression of IFN-γ transcripts. The present study provides the first association of TNF-α promoter demethylation in DENV infected individuals and demonstrates a correlation between the methylation status of the region analyzed and the expression of TNF-α transcripts in DENV infected patients. J. Med. Virol. 88:1297-1302, 2016. © 2016 Wiley Periodicals, Inc.


Subject(s)
DNA Methylation , Dengue Virus/immunology , Dengue/genetics , Dengue/immunology , Promoter Regions, Genetic , Tumor Necrosis Factor-alpha/genetics , Adult , CpG Islands , Female , Humans , Interferon-gamma/genetics , Interferon-gamma/immunology , Male , Middle Aged , Polymerase Chain Reaction , RNA, Viral/blood , RNA, Viral/isolation & purification , Tumor Necrosis Factor-alpha/immunology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...